Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47. Hu H, Cheng R, Wang Y, Wang X, et al. J Clin Invest 2023;133:e153470.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hu H, Cheng R, Wang Y, Wang X, et al. Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47. J Clin Invest 2023;133:e153470.
PMID: 36413402